New computational tool uncovers hidden genes behind heart and metabolic diseases

Genetic changes can signal evidence of disease, but pinpointing which genes and what's changed can be difficult.

But in a study of traits that offer clues of a person's cardiovascular health-such as lipid and glucose levels and inflammation-a team of researchers at Case Western Reserve University devised a computational method and tool to improve how genes and genetic changes that cause diseases are identified.

Their new approach could allow doctors to detect and treat so-called cardiometabolic diseases earlier in their development.

We have been able to identify new genes that were previously overlooked, expanding our knowledge of genetic basis of diseases."

Xiaofeng Zhu, lead researcher, professor in the Department of Population and Quantitative Health Sciences at the Case Western Reserve School of Medicine

Their findings were recently published in the journal Nature Communications.

New tool

For this study, the team focused on cardiometabolic health-the overall well-being of your heart and blood vessels and how your body breaks down food to create energy.

The researchers used existing so-called "genome-wide association studies" (GWAS), which can identify areas in a person's DNA linked to traits found in cardiovascular diseases.

But even these types of studies are inexact. Identifying which gene or change is causing the disease is difficult because genes can overlap and interconnect, contributing to the complexity and efficiency. The genetic changes can affect the DNA in indirect or hidden ways-like turning genes on or off or working far from where they're located-all affect how genes function.

But building on this approach, the team developed a new computationally effective tool to pinpoint the genes and probable changes in a particular region of a person's DNA. (The researchers labeled their tool TGVIS, for Tissue-Gene pairs, direct casual Variants, and Infinitesimal Effects Selector.)

"We used TGVIS to study 45 traits related to heart and metabolism, using genomic data from 31 different types of body tissues," Zhu said. "This helped us better identify which genes are likely causing these traits. We even found new genes that previous studies missed."

How it works

Their method combines information from GWAS with other biological data-such as how your body uses the instructions in your DNA to make things it needs like protein and molecules that help our bodies function. Using advanced math and computer calculations, the data is merged to identify which genes and DNA changes might be causing those diseases.

While the TGVIS tool was applied to cardiometabolic traits, its method could be adapted to study other diseases. Zhu is now looking to identify traits for breast cancer, Alzheimer's disease and cardiovascular diseases.

"We can also now prioritize which genes to study further," Zhu said, "making research more efficient and focused, which can accelerate the pace of scientific discoveries and innovations."

Yihe Yang, a postdoctoral fellow in Zhu's lab, took a leading role in the study. Noah Lorinez-Comi, a former PhD student in the lab, also contributed to the research.

Source:
Journal reference:

Yang, Y., et al. (2025). Uncovering causal gene-tissue pairs and variants through a multivariate TWAS controlling for infinitesimal effects. Nature Communications. doi.org/10.1038/s41467-025-61423-8.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
New cellular entry pathway improves gene therapy outcomes